Screener
Sana Biotechnology SANA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 35,845 | 38,313 |
| Intangible asset | 59,195 | 59,195 |
| Goodwill | 140,627 | 140,627 |
| Other non-current assets | 563 | 3,173 |
| TOTAL ASSETS | $373,593 | $416,890 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,123 | $1,669 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's other non-current assets?
- Sana Biotechnology (SANA) reported other non-current assets of $563K in Q1 2026.
- How has Sana Biotechnology's other non-current assets changed year-over-year?
- Sana Biotechnology's other non-current assets decreased by 87.2% year-over-year, from $4.39M to $563K.
- What is the long-term trend for Sana Biotechnology's other non-current assets?
- Over 5 years (2020 to 2025), Sana Biotechnology's other non-current assets has grown at a 75.6% compound annual growth rate (CAGR), from $190K to $3.17M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Sana Biotechnology's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude